| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 331,276 | 319,815 | 303,885 | 297,815 | | Cost of Revenue | (372,664) | 217,195 | 194,008 | 194,969 | | | Gross Profit | 703,940 | 102,620 | 109,877 | 102,846 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 621,641 | 23,654 | 49,291 | 33,444 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,956 | 4,187 | 3,963 | 4,020 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 78,343 | 74,779 | 56,623 | 65,382 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 430 | 429 | 441 | 537 | | Earnings Before Interest And Taxes | 78,773 | 75,208 | 57,064 | 65,919 | | Interest Expense | 570 | 824 | 1,011 | 1,747 | | Income Before Tax | 78,203 | 74,384 | 56,053 | 64,172 | | Income Tax Expense | 30,069 | 31,167 | 22,001 | 25,187 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 48,134 | 43,217 | 34,052 | 38,985 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 48,134 | 43,217 | 34,052 | 38,985 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $48,134 | $43,217 | $34,052 | $38,985 |
|
0.83% Nasdaq 
Income Statement
